Holen Sie sich die Stockscreener-App
38.50
0.92%
0.35
Handel nachbörslich:
38.50
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Virtus Advisers LLC Makes New Investment in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Tieton Capital Management LLC Takes Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Denali Advisors LLC Purchases 29,700 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Stephen M. Mollichella Net Worth (2026) - GuruFocus
Aurora Investment Counsel Invests $2.37 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Did Strong Q2 Earnings and Completed Buybacks Just Shift Harmony Biosciences' (HRMY) Investment Narrative? - simplywall.st
Chase Investment Counsel Corp Takes $1.82 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - stocktwits.com
Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline - MarketBeat
HRMY: Record WAKIX sales drive CNS pipeline progress, with BP-205 and new pitolisant forms advancing - TradingView
Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP) - The Globe and Mail
Zacks Research Downgrades Harmony Biosciences (NASDAQ:HRMY) to Hold - MarketBeat
Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo Finance
Harmony Sets Investor Appearance as CNS Strategy Advances - MyChesCo
Hennion & Walsh Asset Management Inc. Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring an 18% Potential Upside with Strong Revenue Growth - DirectorsTalk Interviews
Harmony Biosciences Holdings, Inc. $HRMY Shares Sold by Janus Henderson Group PLC - MarketBeat
(HRMY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Surge And Pipeline Progress - Sahm
Harmony Profit Jumps as WAKIX Revenue Climbs 30% - MyChesCo
Harmony Biosciences (NASDAQ:HRMY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Jump And Pipeline ProgressWhat's Changed - Yahoo Finance
Harmony Biosciences (NASDAQ: HRMY) holder to sell 700,883 shares - Stock Titan
Harmony Biosciences Holdings, Inc. Just Recorded A 34% EPS Beat: Here's What Analysts Are Forecasting Next - Moomoo
First Trust Advisors LP Sells 50,805 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings Inc (HRMY) Stock News Today - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium - The Manila Times
Harmony Biosciences management plans Aug. 13 fireside chat webcast - Stock Titan
Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated (HRMY) - Seeking Alpha
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up - Yahoo Finance
Analysts Are Bullish on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Beam Therapeutics (BEAM) - The Globe and Mail
Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now - Yahoo Finance
Deutsche Bank Adjusts Harmony Biosciences Price Target to $39 From $36, Maintains Hold Rating - marketscreener.com
Harmony Biosciences Says New Data Supports Neurology Pipeline - benzinga.com
Harmony Biosciences Holdings, Inc. $HRMY Stock Holdings Lifted by Pacer Advisors Inc. - MarketBeat
Harmony Biosciences Q2 2026 slides: record WAKIX quarter, BP-205 data - Investing.com
Sei Investments Co. Has $5.44 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Q2 2026 earnings: WAKIX revenue rises 30% - TradingKey
Harmony Biosciences Holdings Inc (HRMY) (Q2 2026) Earnings Call - GuruFocus
Harmony Biosciences Holdings, Inc. Stock 12‑Month Price Target Cut to $44.7, Implies 26% Upside - TradingView
Harmony Biosciences Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Harmony Biosciences Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HRMY) 2026-08-04 - Seeking Alpha
Harmony Biosciences Holdings Inc (HRMY) (Q2 2026) Earnings Call Highlights: Record Revenue and ... - Yahoo Finance UK
Harmony Biosciences Holdings Surges 11.0% Amid Sector-Wide Rally - AlphaStreet
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer - StreetInsider
Oppenheimer lowers Harmony Biosciences stock price target on model updates - Investing.com
Needham & Company LLC Forecasts Strong Price Appreciation for Harmony Biosciences (NASDAQ:HRMY) Stock - MarketBeat
Is Harmony Biosciences (HRMY) Undervalued After Q2 Earnings? EPS - GuruFocus
Harmony Biosciences Q2 Earnings Call Highlights - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Stock Price Up 11.4% Following Strong Earnings - MarketBeat
Harmony Biosciences Shares Rise After Q2 Earnings, Product Revenue Increase - marketscreener.com
Harmony Biosciences Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Harmony Biosciences 2Q 2026: Revenue $261.28M, EPS $1.28— 10-Q Summary - tradingview.com
Harmony Biosciences (NASDAQ: HRMY) lifts Q2 profit as WAKIX sales grow - Stock Titan
(HRMY) Harmony Biosciences Expects 2026 Wakix Net Revenue Range $1.0B to $1.04B - marketscreener.com
Earnings Flash (HRMY) Harmony Biosciences Posts Q2 EPS $1.28, vs. FactSet Est of $0.96 - marketscreener.com
Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile - The Manila Times
Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook with a Promising 27.81% Potential Upside - DirectorsTalk Interviews
Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Q2 2026 -- GF Value Sees 57% Upside - Yahoo Finance
0.00%
3.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):